Low serum free testosterone level is associated with carotid intima-media thickness in middle-aged Japanese men

Endocrine Journal

Volumn 59, Issue 9, 2012, Pages 809-815

  Tsujimura, Akira ^a   Yamamoto, Ryohei ^a   Okuda, Hidenobu ^a   Yamamoto, Keisuke ^a   Fukuhara, Shinichiro ^a   Yoshioka, Iwao ^a   Kiuchi, Hiroshi ^a   Takao, Tetsuya ^a   Miyagawa, Yasushi ^a   Nishida, Makoto ^b   Yamauchi Takihara, Keiko ^b   Moriyama, Toshiki ^b   Nonomura, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Carotid artery; Free testosterone; Intima media thickness; Men

Indexed keywords

ANTIHYPERTENSIVE AGENT; TESTOSTERONE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; NON INVASIVE MEASUREMENT; RADIOIMMUNOASSAY; RISK ASSESSMENT; TESTOSTERONE BLOOD LEVEL;

ADULT; AGE FACTORS; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; HOSPITALS, UNIVERSITY; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENT CLINICS, HOSPITAL; QUESTIONNAIRES; RADIOIMMUNOASSAY; RISK FACTORS; TESTOSTERONE;

EID: 84867914123     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0060     Document Type: Article

References (42)

1. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, et al. (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol 48:1-4.
2. Morley JE (2001) Androgens and aging. Maturitas 38:61-71.
3. Morales A, Buvat J, Gooren LJ, Guay AT, Kaufman JM, et al. (2004) Endocrine aspects of sexual dysfunction in men. J Sex Med 1:69-81.
4. Morley JE, Perry HM (1999) Androgen deficiency in aging men. Med Clin North Am 83:1279-1289.
5. Vermeulen A (2000) Andropause. Maturitas 34:5-15.
6. Morales A, Heaton JP, Carson CC (2000) Andropause: a misnomer for a true clinical entity. J Urol 163:705-712.
7. Tsujimura A, Matsumiya K, Matsuoka Y, Takahashi T, Koga M, et al. (2003) Bioavailable testosterone with age and erectile dysfunction. J Urol 170:2345-2347.
8. Haring R, Volzke H, Steveling A, Krebs A, Felix SB, et al. (2010) Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J 31:1494-1501.
9. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, et al. (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116:2694-2701.
10. Menke A, Guallar E, Rohrmann S, Nelson WG, Rifai N, et al. (2010) Sex steroid hormone concentrations and risk of death in US men. Am J Epidemiol 171:583-592.
11. Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, et al. (2007) Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertens Res 30:1029-1034.
12. Makinen J, Jarvisalo MJ, Pollanen P, Perheentupa A, Irjala K, et al. (2005) Increased carotid atherosclerosis in andropausal middle-aged men. J Am Coll Cardiol 45:1603-1608.
13. Imai E, Yamagata K, Iseki K, Iso H, Horio M, et al. (2007) Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol 2:1360-1366.
14. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982-992.
15. Nishida M, Moriyama T, Ishii K, Takashima S, Yoshizaki K, et al. (2007) Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis. Clin Chim Acta 384:99-104.
16. Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K (2007) Interleukin-10 associates with adiponectin predominantly in subjects with metabolic syndrome. Circ J 71:1234-1238.
17. Yanase T, Nasu S, Mukuta Y, Shimizu Y, Nishihara T, et al. (2006) Evaluation of a new carotid intimal plus medial thickness (IMT) measurement by b-mode ultrasonography using an innovative measurement software, intimascope. Am J Hypertension 19:1206-1212.
18. Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, et al. (2010) Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors. Atherosclerosis 210:232-236.
19. Friedrich N, Rosskopf D, Brabant G, Volzke H, Nauck M, et al. (2010) Associations of anthropometric parameters with serum TSH, prolactin, IGF-I, and testosterone levels: results of the study of health in Pomerania (SHIP). Exp Clin Endocrinol Diabetes 118:266-273.
20. Khaw KT, Barrett-Connor E (1988) Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertens 6:329-332.
21. Grossmann M (2011) Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab 96:2341-2353.
22. Haring R, Volzke H, Felix SB, Schipf S, Dorr M, et al. (2009) Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes 58:2027-2031.
23. Bots ML, Hoes AW, Hofman A, Witteman JC, Grobbee DE (1999) Cross-sectionally assessed carotid intimamedia thickness relates to long-term risk of stroke, coronary heart disease and death as estimated by available risk functions. J Intern Med 245:269-276.
24. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, et al. (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14-22.
25. Salonen JT, Salonen R (1991) Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 11:1245-1249.
26. van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, et al. (2003) Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 157:25-31.
27. Fukui M, Kitagawa Y, Nakamura N, Kadono M, Mogami S, et al. (2003) Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes. Diabetes Care 26:1869-1873.
28. De Pergola G, Pannacciulli N, Ciccone M, Tartagni M, Rizzon P, et al. (2003) Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men. Int J Obes Relat Metab Disord 27:803-807.
29. Svartberg J, von Muhlen D, Mathiesen E, Joakimsen O, Bonaa KH, et al. (2006) Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med 259:576-582.
30. Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SW, et al. (2004) Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 109:2074-2079.
31. Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS (2003) Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development and stability. J Endocrinol 178:373-380.
32. Fu L, Gao QP, Shen JX (2008) Relationship between testosterone and indexes indicating endothelial function in male coronary heart disease patients. Asian J Androl 10:214-218.
33. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C (1999) Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84:813-819.
34. Nathan L, Shi W, Dinh H, Mukherjee TK, Wang X, et al. (2001) Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci U S A 98:3589-3593.
35. Aversa A, Bruzziches R, Francomano D, Rosano G, Isidori AM, et al. (2010) Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study. J Sex Med 7:3495-3503.
36. Mathur A, Malkin C, Saeed B, Muthusamy R, Jones TH, et al. (2009) Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men. Eur J Endocrinol 161:443-449.
37. Namiki M, Akaza H, Shimazui T, Ito N, Iwamoto T, et al. (2008) Clinical practice manual for late-onset hypogonadism syndrome. Int J Urol 15:377-388.
38. Wilke TJ, Utley DJ (1987) Total testosterone, free-androgen index, calculated free testosterone, and free testosterone by analog RIA compared in hirsute women and in otherwise-normal women with altered binding of sex-hormone-binding globulin. Clin Chem 33:1372-1375.
39. Rosner W (1997) Errors in the measurement of plasma free testosterone. J Clin Endocrinol Metab 82:2014-2015.
40. Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672.
41. Morales A, Lunenfeld B (2002) Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 5:74-86.
42. Moreno SA, Shyam A, Morgentaler A (2010) Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population. J Sex Med 7:1948-1953.